Recipharm is a Manufacturer/Innovator, Contract Service company operating in the pharmaceutical industry.
Established in 1995, Recipharm’s manufacturing, fill & finish, and delivery-device services encompass a wide variety of drug dosage forms and modalities. Recipharm is an industry leading CDMO with over 30 facilities and 9,000 employees globally – supporting companies that are developing small molecules, biologics, and drug-device combinations. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US.
Company type
Manufacturer/Innovator, Contract Service
Products and services
Biopharmaceuticals, Custom Manufacturing, Finished Dosage Forms, Pharmaceutical Packaging, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Recipharm on LinkedIn
Address
Recipharm, Box 603, Stockholm, Sweden, 10132
